Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2010 Jun;62(6):791–799. doi: 10.1002/acr.20160

Table 2.

Descriptive statistics for side effects, medications, and beliefs about medicines at baseline and 6-month follow-up

Variables Patient numbers
Baseline (n = 100) Follow-up (n = 87)
Side Effects Scale (M, SD, Cronbach’s alpha) 4.31 ± 2.31, α=.81 2.24 ± 1.81, α=.84
 Bothered by side effects from arthritis medication (1-5), (M, SD) 2.72 ± 1.33 1.68 ± 0.98
 Self-changed prescribed medication due to side effects 51 (51 %) 17 (19.5 %)
 Taken non-prescribed medication to relieve side effects 38 (38 %) 15 (17.2 %)
 Reported any side effects to your doctor 70 (70 %) 21 (27.7 %)
Incidence of side effects § 77 (77%) 45 (51.7%)
Type of side effects in free format #
 Abdominal discomfort (stomach pain, cramps, etc.) 27 (27 %) 15 (17.2 %)
 Skin reactions (rash, ulcer, sores, allergies) 18 (18 %) 7 (8.0 %)
 Nausea 15 (15 %) 8 (9.2 %)
 Weight loss/gain 12 (12 %) 3 (3.4 %)
 Fatigue 10 (10 %) 5 (5.7 %)
 Diarrhea, vomiting 7 (7 %) 1 (1.1 %)
 Headache 5 (5 %) 5 (5.7 %)
Medication regimen
 Symptomatic drugs 73 (73 %) 60 (68.9 %)
 Steroids 30 (30 %) 25 (28.7 %)
 DMARDs 58 (58 %) 45 (51.7 %)
 Biologic response modifiers 48 (48 %) 44 (50.6 %)
 New drug prescription within 6-months follow-up - 17 (19.5 %)
BMQ subscales (M, SD, Cronbach’s alpha)
 General Harm (1-20) 8.86 ± 2.83, α=.68 8.57 ± 2.47, α=.61
 General Overuse (1-20) 11.56 ± 3.09, α=.74 11.21 ± 2.78, α=.69
 Specific Necessity (1-25) 19.63 ± 3.77, α=.82 19.62 ± 3.72, α=.81
 Specific Concern (1-30) 17.01 ± 4.29, α=.73 16.63 ± 3.73, α=.71

Note. M = Mean; SD = standard deviation

§

Incidence was defined as the proportion of patients who were at least mildly bothered by side effects or agreed to any of the other three side effect questions

#

Reported are side effects with a base rate > 5%; DMARDs = Disease modifying anti-rheumatic drugs; BMQ = Beliefs about Medicines Questionnaire.